During the past decade, Azienda Ospedaliera S.Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliera S.Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico" are "Follicular Lymphoma" (2 trials), "Hodgkin Lymphoma" (2 trials), "Classical Hodgkin Lymphoma" (1 trials), "Lymphoma" (1 trials) and "Primary Mediastinal Large B-cell Lymphoma (PMBCL)" (1 trials). Many other conditions were trialed in "Azienda Ospedaliera S.Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliera S.Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Doxorubicin" (2 trials), "Bendamustine" (1 trials), "Bleomycin" (1 trials), "Cyclophosphamide" (1 trials) and "Dacarbazine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliera S.Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Azienda Ospedaliera S.Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Azienda Ospedaliera S.Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliera S.Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".